Radiopharm Theranostics Files March 2025 6-K

Ticker: RDPTF · Form: 6-K · Filed: Mar 7, 2025 · CIK: 1949257

Radiopharm Theranostics Ltd 6-K Filing Summary
FieldDetail
CompanyRadiopharm Theranostics Ltd (RDPTF)
Form Type6-K
Filed DateMar 7, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: reporting, foreign-private-issuer

TL;DR

Radiopharm Theranostics (RPT) filed its March 6-K, confirming foreign private issuer status.

AI Summary

Radiopharm Theranostics Limited filed a Form 6-K on March 7, 2025, reporting for the month of March 2025. The company is a foreign private issuer and is not furnishing information under Rule 12g3-2(b). Their principal executive office is located in Carlton South, Victoria, Australia.

Why It Matters

This filing indicates ongoing reporting compliance for Radiopharm Theranostics Limited as a foreign private issuer, providing transparency to investors about their regulatory status.

Risk Assessment

Risk Level: low — This filing is a routine report of foreign private issuer status and does not contain new financial or operational information that would typically increase risk.

Key Players & Entities

  • Radiopharm Theranostics Limited (company) — Registrant
  • 001-41621 (company) — SEC File Number
  • March 2025 (date) — Reporting Period
  • Carlton South, Victoria, Australia (location) — Principal Executive Office

FAQ

What is the purpose of a Form 6-K filing?

A Form 6-K is a report of foreign private issuers that provides information which the issuer makes or is required to make public pursuant to the laws of its home country, or which it furnishes or makes public to its security holders.

Is Radiopharm Theranostics Limited furnishing information under Rule 12g3-2(b)?

No, the filing explicitly states 'No' next to the indication for Rule 12g3-2(b).

What is the SEC file number for Radiopharm Theranostics Limited?

The SEC file number for Radiopharm Theranostics Limited is 001-41621.

Where is Radiopharm Theranostics Limited's principal executive office located?

The principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.

What period does this Form 6-K report cover?

This Form 6-K reports for the month of March 2025.

Filing Details

This Form 6-K (Form 6-K) was filed with the SEC on March 7, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).

View full filing on EDGAR

View Full Filing

View this 6-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.